---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-133745"
form_type: "8-K"
ticker: "TSHA"
cik: "0001806310"
company_name: "Taysha Gene Therapies, Inc."
filed_at: "2025-06-03T23:59:59+00:00"
generated_at: "2026-05-20T01:50:14.154383+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Taysha Gene Therapies shareholders approve authorized share increase to 700M

## Summary
- Authorized common stock increased from 400M to 700M shares; approved 171.3M for, 8.2M against.
- Directors Phillip B. Donenberg and Sukumar Nagendran elected with 114.3M and 123.3M votes for, respectively.
- Deloitte & Touche ratified as independent auditor for FY2025; 179.4M votes for.
- Annual meeting turnout: 179.6M shares (~87%) of 205.1M outstanding represented.

## SEC filing metadata
- accession: 0001193125-25-133745
- form_type: 8-K
- ticker: TSHA
- cik: 0001806310
- company_name: Taysha Gene Therapies, Inc.
- filed_at: 2025-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1806310/000119312525133745/0001193125-25-133745-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1806310/000119312525133745/d843671d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-133745
- JSON: https://secwatch.observer/filing/0001193125-25-133745.json
- Plain text: https://secwatch.observer/filing/0001193125-25-133745.txt

## Key facts
- Governance Changes
  Taysha Gene Therapies, Inc.: Increase in authorized common stock from 400,000,000 to 700,000,000 (effective 2025-06-02).
  - Change: charter amendment
  - Effective: 2025-06-02
  source text: At the Annual Meeting, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “ Amendment ”) to increase the authorized number of shares of common stock from 400,000,000 to 700,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1806310/000119312525133745/0001193125-25-133745-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.